Global AI Pharma Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global AI Pharma market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global AI Pharma market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Pharma market size and forecasts, in consumption value ($ Million), 2020-2031
Global AI Pharma market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global AI Pharma market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global AI Pharma market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Pharma
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Pharma market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recursion, Insilico Medicine, Exscientia, BenevolentAI, Atomwise, Roivant Sciences, Schrцdinger, Lantern Pharma, XtalPi, Landos Biopharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Pharma market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Pharma product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Pharma, with revenue, gross margin, and global market share of AI Pharma from 2020 to 2025.
Chapter 3, the AI Pharma competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and AI Pharma market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Pharma.
Chapter 13, to describe AI Pharma research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global AI Pharma market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Pharma market size and forecasts, in consumption value ($ Million), 2020-2031
Global AI Pharma market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global AI Pharma market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global AI Pharma market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Pharma
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Pharma market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recursion, Insilico Medicine, Exscientia, BenevolentAI, Atomwise, Roivant Sciences, Schrцdinger, Lantern Pharma, XtalPi, Landos Biopharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Pharma market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Self-developed Oipeline
- Contract Research Organization (CRO)
- Other
- Preclinical Stage (Optimization of Lead Compounds, etc.)
- Clinical Trial Phase (Predicting Treatment Outcome, etc.)
- Recursion
- Insilico Medicine
- Exscientia
- BenevolentAI
- Atomwise
- Roivant Sciences
- Schrцdinger
- Lantern Pharma
- XtalPi
- Landos Biopharma
- Relay Therapeutics
- Accutar Biotech
- Deep Genomics
- Oncocross
- AI Therapeutics
- BioMap
- METiS Pharmaceuticals
- NeoX Biotech
- StoneWise
- Deep Intelligent Pharma
- Gigaceuticals
- Chemical.AI
- Artivila
- Galixir
- Xbiome
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Pharma product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Pharma, with revenue, gross margin, and global market share of AI Pharma from 2020 to 2025.
Chapter 3, the AI Pharma competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and AI Pharma market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Pharma.
Chapter 13, to describe AI Pharma research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Pharma by Type
1.3.1 Overview: Global AI Pharma Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global AI Pharma Consumption Value Market Share by Type in 2024
1.3.3 Self-developed Oipeline
1.3.4 Contract Research Organization (CRO)
1.3.5 Other
1.4 Global AI Pharma Market by Application
1.4.1 Overview: Global AI Pharma Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Preclinical Stage (Optimization of Lead Compounds, etc.)
1.4.3 Clinical Trial Phase (Predicting Treatment Outcome, etc.)
1.5 Global AI Pharma Market Size & Forecast
1.6 Global AI Pharma Market Size and Forecast by Region
1.6.1 Global AI Pharma Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global AI Pharma Market Size by Region, (2020-2031)
1.6.3 North America AI Pharma Market Size and Prospect (2020-2031)
1.6.4 Europe AI Pharma Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific AI Pharma Market Size and Prospect (2020-2031)
1.6.6 South America AI Pharma Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa AI Pharma Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Recursion
2.1.1 Recursion Details
2.1.2 Recursion Major Business
2.1.3 Recursion AI Pharma Product and Solutions
2.1.4 Recursion AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Recursion Recent Developments and Future Plans
2.2 Insilico Medicine
2.2.1 Insilico Medicine Details
2.2.2 Insilico Medicine Major Business
2.2.3 Insilico Medicine AI Pharma Product and Solutions
2.2.4 Insilico Medicine AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Insilico Medicine Recent Developments and Future Plans
2.3 Exscientia
2.3.1 Exscientia Details
2.3.2 Exscientia Major Business
2.3.3 Exscientia AI Pharma Product and Solutions
2.3.4 Exscientia AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Exscientia Recent Developments and Future Plans
2.4 BenevolentAI
2.4.1 BenevolentAI Details
2.4.2 BenevolentAI Major Business
2.4.3 BenevolentAI AI Pharma Product and Solutions
2.4.4 BenevolentAI AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 BenevolentAI Recent Developments and Future Plans
2.5 Atomwise
2.5.1 Atomwise Details
2.5.2 Atomwise Major Business
2.5.3 Atomwise AI Pharma Product and Solutions
2.5.4 Atomwise AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Atomwise Recent Developments and Future Plans
2.6 Roivant Sciences
2.6.1 Roivant Sciences Details
2.6.2 Roivant Sciences Major Business
2.6.3 Roivant Sciences AI Pharma Product and Solutions
2.6.4 Roivant Sciences AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Roivant Sciences Recent Developments and Future Plans
2.7 Schrцdinger
2.7.1 Schrцdinger Details
2.7.2 Schrцdinger Major Business
2.7.3 Schrцdinger AI Pharma Product and Solutions
2.7.4 Schrцdinger AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Schrцdinger Recent Developments and Future Plans
2.8 Lantern Pharma
2.8.1 Lantern Pharma Details
2.8.2 Lantern Pharma Major Business
2.8.3 Lantern Pharma AI Pharma Product and Solutions
2.8.4 Lantern Pharma AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Lantern Pharma Recent Developments and Future Plans
2.9 XtalPi
2.9.1 XtalPi Details
2.9.2 XtalPi Major Business
2.9.3 XtalPi AI Pharma Product and Solutions
2.9.4 XtalPi AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 XtalPi Recent Developments and Future Plans
2.10 Landos Biopharma
2.10.1 Landos Biopharma Details
2.10.2 Landos Biopharma Major Business
2.10.3 Landos Biopharma AI Pharma Product and Solutions
2.10.4 Landos Biopharma AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Landos Biopharma Recent Developments and Future Plans
2.11 Relay Therapeutics
2.11.1 Relay Therapeutics Details
2.11.2 Relay Therapeutics Major Business
2.11.3 Relay Therapeutics AI Pharma Product and Solutions
2.11.4 Relay Therapeutics AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Relay Therapeutics Recent Developments and Future Plans
2.12 Accutar Biotech
2.12.1 Accutar Biotech Details
2.12.2 Accutar Biotech Major Business
2.12.3 Accutar Biotech AI Pharma Product and Solutions
2.12.4 Accutar Biotech AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Accutar Biotech Recent Developments and Future Plans
2.13 Deep Genomics
2.13.1 Deep Genomics Details
2.13.2 Deep Genomics Major Business
2.13.3 Deep Genomics AI Pharma Product and Solutions
2.13.4 Deep Genomics AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Deep Genomics Recent Developments and Future Plans
2.14 Oncocross
2.14.1 Oncocross Details
2.14.2 Oncocross Major Business
2.14.3 Oncocross AI Pharma Product and Solutions
2.14.4 Oncocross AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Oncocross Recent Developments and Future Plans
2.15 AI Therapeutics
2.15.1 AI Therapeutics Details
2.15.2 AI Therapeutics Major Business
2.15.3 AI Therapeutics AI Pharma Product and Solutions
2.15.4 AI Therapeutics AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 AI Therapeutics Recent Developments and Future Plans
2.16 BioMap
2.16.1 BioMap Details
2.16.2 BioMap Major Business
2.16.3 BioMap AI Pharma Product and Solutions
2.16.4 BioMap AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 BioMap Recent Developments and Future Plans
2.17 METiS Pharmaceuticals
2.17.1 METiS Pharmaceuticals Details
2.17.2 METiS Pharmaceuticals Major Business
2.17.3 METiS Pharmaceuticals AI Pharma Product and Solutions
2.17.4 METiS Pharmaceuticals AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 METiS Pharmaceuticals Recent Developments and Future Plans
2.18 NeoX Biotech
2.18.1 NeoX Biotech Details
2.18.2 NeoX Biotech Major Business
2.18.3 NeoX Biotech AI Pharma Product and Solutions
2.18.4 NeoX Biotech AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 NeoX Biotech Recent Developments and Future Plans
2.19 StoneWise
2.19.1 StoneWise Details
2.19.2 StoneWise Major Business
2.19.3 StoneWise AI Pharma Product and Solutions
2.19.4 StoneWise AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 StoneWise Recent Developments and Future Plans
2.20 Deep Intelligent Pharma
2.20.1 Deep Intelligent Pharma Details
2.20.2 Deep Intelligent Pharma Major Business
2.20.3 Deep Intelligent Pharma AI Pharma Product and Solutions
2.20.4 Deep Intelligent Pharma AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Deep Intelligent Pharma Recent Developments and Future Plans
2.21 Gigaceuticals
2.21.1 Gigaceuticals Details
2.21.2 Gigaceuticals Major Business
2.21.3 Gigaceuticals AI Pharma Product and Solutions
2.21.4 Gigaceuticals AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Gigaceuticals Recent Developments and Future Plans
2.22 Chemical.AI
2.22.1 Chemical.AI Details
2.22.2 Chemical.AI Major Business
2.22.3 Chemical.AI AI Pharma Product and Solutions
2.22.4 Chemical.AI AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Chemical.AI Recent Developments and Future Plans
2.23 Artivila
2.23.1 Artivila Details
2.23.2 Artivila Major Business
2.23.3 Artivila AI Pharma Product and Solutions
2.23.4 Artivila AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Artivila Recent Developments and Future Plans
2.24 Galixir
2.24.1 Galixir Details
2.24.2 Galixir Major Business
2.24.3 Galixir AI Pharma Product and Solutions
2.24.4 Galixir AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 Galixir Recent Developments and Future Plans
2.25 Xbiome
2.25.1 Xbiome Details
2.25.2 Xbiome Major Business
2.25.3 Xbiome AI Pharma Product and Solutions
2.25.4 Xbiome AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Xbiome Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Pharma Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of AI Pharma by Company Revenue
3.2.2 Top 3 AI Pharma Players Market Share in 2024
3.2.3 Top 6 AI Pharma Players Market Share in 2024
3.3 AI Pharma Market: Overall Company Footprint Analysis
3.3.1 AI Pharma Market: Region Footprint
3.3.2 AI Pharma Market: Company Product Type Footprint
3.3.3 AI Pharma Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Pharma Consumption Value and Market Share by Type (2020-2025)
4.2 Global AI Pharma Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Pharma Consumption Value Market Share by Application (2020-2025)
5.2 Global AI Pharma Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America AI Pharma Consumption Value by Type (2020-2031)
6.2 North America AI Pharma Market Size by Application (2020-2031)
6.3 North America AI Pharma Market Size by Country
6.3.1 North America AI Pharma Consumption Value by Country (2020-2031)
6.3.2 United States AI Pharma Market Size and Forecast (2020-2031)
6.3.3 Canada AI Pharma Market Size and Forecast (2020-2031)
6.3.4 Mexico AI Pharma Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe AI Pharma Consumption Value by Type (2020-2031)
7.2 Europe AI Pharma Consumption Value by Application (2020-2031)
7.3 Europe AI Pharma Market Size by Country
7.3.1 Europe AI Pharma Consumption Value by Country (2020-2031)
7.3.2 Germany AI Pharma Market Size and Forecast (2020-2031)
7.3.3 France AI Pharma Market Size and Forecast (2020-2031)
7.3.4 United Kingdom AI Pharma Market Size and Forecast (2020-2031)
7.3.5 Russia AI Pharma Market Size and Forecast (2020-2031)
7.3.6 Italy AI Pharma Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Pharma Consumption Value by Type (2020-2031)
8.2 Asia-Pacific AI Pharma Consumption Value by Application (2020-2031)
8.3 Asia-Pacific AI Pharma Market Size by Region
8.3.1 Asia-Pacific AI Pharma Consumption Value by Region (2020-2031)
8.3.2 China AI Pharma Market Size and Forecast (2020-2031)
8.3.3 Japan AI Pharma Market Size and Forecast (2020-2031)
8.3.4 South Korea AI Pharma Market Size and Forecast (2020-2031)
8.3.5 India AI Pharma Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia AI Pharma Market Size and Forecast (2020-2031)
8.3.7 Australia AI Pharma Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America AI Pharma Consumption Value by Type (2020-2031)
9.2 South America AI Pharma Consumption Value by Application (2020-2031)
9.3 South America AI Pharma Market Size by Country
9.3.1 South America AI Pharma Consumption Value by Country (2020-2031)
9.3.2 Brazil AI Pharma Market Size and Forecast (2020-2031)
9.3.3 Argentina AI Pharma Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Pharma Consumption Value by Type (2020-2031)
10.2 Middle East & Africa AI Pharma Consumption Value by Application (2020-2031)
10.3 Middle East & Africa AI Pharma Market Size by Country
10.3.1 Middle East & Africa AI Pharma Consumption Value by Country (2020-2031)
10.3.2 Turkey AI Pharma Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia AI Pharma Market Size and Forecast (2020-2031)
10.3.4 UAE AI Pharma Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 AI Pharma Market Drivers
11.2 AI Pharma Market Restraints
11.3 AI Pharma Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Pharma Industry Chain
12.2 AI Pharma Upstream Analysis
12.3 AI Pharma Midstream Analysis
12.4 AI Pharma Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global AI Pharma Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global AI Pharma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global AI Pharma Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global AI Pharma Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Recursion Company Information, Head Office, and Major Competitors
Table 6. Recursion Major Business
Table 7. Recursion AI Pharma Product and Solutions
Table 8. Recursion AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Recursion Recent Developments andFuture Plans
Table 10. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 11. Insilico Medicine Major Business
Table 12. Insilico Medicine AI Pharma Product and Solutions
Table 13. Insilico Medicine AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Insilico Medicine Recent Developments andFuture Plans
Table 15. Exscientia Company Information, Head Office, and Major Competitors
Table 16. Exscientia Major Business
Table 17. Exscientia AI Pharma Product and Solutions
Table 18. Exscientia AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. BenevolentAI Company Information, Head Office, and Major Competitors
Table 20. BenevolentAI Major Business
Table 21. BenevolentAI AI Pharma Product and Solutions
Table 22. BenevolentAI AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. BenevolentAI Recent Developments andFuture Plans
Table 24. Atomwise Company Information, Head Office, and Major Competitors
Table 25. Atomwise Major Business
Table 26. Atomwise AI Pharma Product and Solutions
Table 27. Atomwise AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Atomwise Recent Developments andFuture Plans
Table 29. Roivant Sciences Company Information, Head Office, and Major Competitors
Table 30. Roivant Sciences Major Business
Table 31. Roivant Sciences AI Pharma Product and Solutions
Table 32. Roivant Sciences AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Roivant Sciences Recent Developments andFuture Plans
Table 34. Schrцdinger Company Information, Head Office, and Major Competitors
Table 35. Schrцdinger Major Business
Table 36. Schrцdinger AI Pharma Product and Solutions
Table 37. Schrцdinger AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Schrцdinger Recent Developments andFuture Plans
Table 39. Lantern Pharma Company Information, Head Office, and Major Competitors
Table 40. Lantern Pharma Major Business
Table 41. Lantern Pharma AI Pharma Product and Solutions
Table 42. Lantern Pharma AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Lantern Pharma Recent Developments andFuture Plans
Table 44. XtalPi Company Information, Head Office, and Major Competitors
Table 45. XtalPi Major Business
Table 46. XtalPi AI Pharma Product and Solutions
Table 47. XtalPi AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. XtalPi Recent Developments andFuture Plans
Table 49. Landos Biopharma Company Information, Head Office, and Major Competitors
Table 50. Landos Biopharma Major Business
Table 51. Landos Biopharma AI Pharma Product and Solutions
Table 52. Landos Biopharma AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Landos Biopharma Recent Developments andFuture Plans
Table 54. RelayTherapeutics Company Information, Head Office, and Major Competitors
Table 55. RelayTherapeutics Major Business
Table 56. RelayTherapeutics AI Pharma Product and Solutions
Table 57. RelayTherapeutics AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. RelayTherapeutics Recent Developments andFuture Plans
Table 59. Accutar Biotech Company Information, Head Office, and Major Competitors
Table 60. Accutar Biotech Major Business
Table 61. Accutar Biotech AI Pharma Product and Solutions
Table 62. Accutar Biotech AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Accutar Biotech Recent Developments andFuture Plans
Table 64. Deep Genomics Company Information, Head Office, and Major Competitors
Table 65. Deep Genomics Major Business
Table 66. Deep Genomics AI Pharma Product and Solutions
Table 67. Deep Genomics AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Deep Genomics Recent Developments andFuture Plans
Table 69. Oncocross Company Information, Head Office, and Major Competitors
Table 70. Oncocross Major Business
Table 71. Oncocross AI Pharma Product and Solutions
Table 72. Oncocross AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Oncocross Recent Developments andFuture Plans
Table 74. AITherapeutics Company Information, Head Office, and Major Competitors
Table 75. AITherapeutics Major Business
Table 76. AITherapeutics AI Pharma Product and Solutions
Table 77. AITherapeutics AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. AITherapeutics Recent Developments andFuture Plans
Table 79. BioMap Company Information, Head Office, and Major Competitors
Table 80. BioMap Major Business
Table 81. BioMap AI Pharma Product and Solutions
Table 82. BioMap AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. BioMap Recent Developments andFuture Plans
Table 84. METiS Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 85. METiS Pharmaceuticals Major Business
Table 86. METiS Pharmaceuticals AI Pharma Product and Solutions
Table 87. METiS Pharmaceuticals AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. METiS Pharmaceuticals Recent Developments andFuture Plans
Table 89. NeoX Biotech Company Information, Head Office, and Major Competitors
Table 90. NeoX Biotech Major Business
Table 91. NeoX Biotech AI Pharma Product and Solutions
Table 92. NeoX Biotech AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. NeoX Biotech Recent Developments andFuture Plans
Table 94. StoneWise Company Information, Head Office, and Major Competitors
Table 95. StoneWise Major Business
Table 96. StoneWise AI Pharma Product and Solutions
Table 97. StoneWise AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 98. StoneWise Recent Developments andFuture Plans
Table 99. Deep Intelligent Pharma Company Information, Head Office, and Major Competitors
Table 100. Deep Intelligent Pharma Major Business
Table 101. Deep Intelligent Pharma AI Pharma Product and Solutions
Table 102. Deep Intelligent Pharma AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 103. Deep Intelligent Pharma Recent Developments andFuture Plans
Table 104. Gigaceuticals Company Information, Head Office, and Major Competitors
Table 105. Gigaceuticals Major Business
Table 106. Gigaceuticals AI Pharma Product and Solutions
Table 107. Gigaceuticals AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 108. Gigaceuticals Recent Developments andFuture Plans
Table 109. Chemical.AI Company Information, Head Office, and Major Competitors
Table 110. Chemical.AI Major Business
Table 111. Chemical.AI AI Pharma Product and Solutions
Table 112. Chemical.AI AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 113. Chemical.AI Recent Developments andFuture Plans
Table 114. Artivila Company Information, Head Office, and Major Competitors
Table 115. Artivila Major Business
Table 116. Artivila AI Pharma Product and Solutions
Table 117. Artivila AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 118. Artivila Recent Developments andFuture Plans
Table 119. Galixir Company Information, Head Office, and Major Competitors
Table 120. Galixir Major Business
Table 121. Galixir AI Pharma Product and Solutions
Table 122. Galixir AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 123. Galixir Recent Developments andFuture Plans
Table 124. Xbiome Company Information, Head Office, and Major Competitors
Table 125. Xbiome Major Business
Table 126. Xbiome AI Pharma Product and Solutions
Table 127. Xbiome AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 128. Xbiome Recent Developments andFuture Plans
Table 129. Global AI Pharma Revenue (USD Million) by Players (2020-2025)
Table 130. Global AI Pharma Revenue Share by Players (2020-2025)
Table 131. Breakdown of AI Pharma by CompanyType (Tier 1,Tier 2, andTier 3)
Table 132. Market Position of Players in AI Pharma, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 133. Head Office of Key AI Pharma Players
Table 134. AI Pharma Market: Company ProductTypeFootprint
Table 135. AI Pharma Market: Company Product ApplicationFootprint
Table 136. AI Pharma New Market Entrants and Barriers to Market Entry
Table 137. AI Pharma Mergers, Acquisition, Agreements, and Collaborations
Table 138. Global AI Pharma Consumption Value (USD Million) byType (2020-2025)
Table 139. Global AI Pharma Consumption Value Share byType (2020-2025)
Table 140. Global AI Pharma Consumption ValueForecast byType (2026-2031)
Table 141. Global AI Pharma Consumption Value by Application (2020-2025)
Table 142. Global AI Pharma Consumption ValueForecast by Application (2026-2031)
Table 143. North America AI Pharma Consumption Value byType (2020-2025) & (USD Million)
Table 144. North America AI Pharma Consumption Value byType (2026-2031) & (USD Million)
Table 145. North America AI Pharma Consumption Value by Application (2020-2025) & (USD Million)
Table 146. North America AI Pharma Consumption Value by Application (2026-2031) & (USD Million)
Table 147. North America AI Pharma Consumption Value by Country (2020-2025) & (USD Million)
Table 148. North America AI Pharma Consumption Value by Country (2026-2031) & (USD Million)
Table 149. Europe AI Pharma Consumption Value byType (2020-2025) & (USD Million)
Table 150. Europe AI Pharma Consumption Value byType (2026-2031) & (USD Million)
Table 151. Europe AI Pharma Consumption Value by Application (2020-2025) & (USD Million)
Table 152. Europe AI Pharma Consumption Value by Application (2026-2031) & (USD Million)
Table 153. Europe AI Pharma Consumption Value by Country (2020-2025) & (USD Million)
Table 154. Europe AI Pharma Consumption Value by Country (2026-2031) & (USD Million)
Table 155. Asia-Pacific AI Pharma Consumption Value byType (2020-2025) & (USD Million)
Table 156. Asia-Pacific AI Pharma Consumption Value byType (2026-2031) & (USD Million)
Table 157. Asia-Pacific AI Pharma Consumption Value by Application (2020-2025) & (USD Million)
Table 158. Asia-Pacific AI Pharma Consumption Value by Application (2026-2031) & (USD Million)
Table 159. Asia-Pacific AI Pharma Consumption Value by Region (2020-2025) & (USD Million)
Table 160. Asia-Pacific AI Pharma Consumption Value by Region (2026-2031) & (USD Million)
Table 161. South America AI Pharma Consumption Value byType (2020-2025) & (USD Million)
Table 162. South America AI Pharma Consumption Value byType (2026-2031) & (USD Million)
Table 163. South America AI Pharma Consumption Value by Application (2020-2025) & (USD Million)
Table 164. South America AI Pharma Consumption Value by Application (2026-2031) & (USD Million)
Table 165. South America AI Pharma Consumption Value by Country (2020-2025) & (USD Million)
Table 166. South America AI Pharma Consumption Value by Country (2026-2031) & (USD Million)
Table 167. Middle East & Africa AI Pharma Consumption Value byType (2020-2025) & (USD Million)
Table 168. Middle East & Africa AI Pharma Consumption Value byType (2026-2031) & (USD Million)
Table 169. Middle East & Africa AI Pharma Consumption Value by Application (2020-2025) & (USD Million)
Table 170. Middle East & Africa AI Pharma Consumption Value by Application (2026-2031) & (USD Million)
Table 171. Middle East & Africa AI Pharma Consumption Value by Country (2020-2025) & (USD Million)
Table 172. Middle East & Africa AI Pharma Consumption Value by Country (2026-2031) & (USD Million)
Table 173. Global Key Players of AI Pharma Upstream (Raw Materials)
Table 174. Global AI PharmaTypical Customers
LIST OFFIGURES
Figure 1. AI Pharma Picture
Figure 2. Global AI Pharma Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global AI Pharma Consumption Value Market Share byType in 2024
Figure 4. Self-developed Oipeline
Figure 5. Contract Research Organization (CRO)
Figure 6. Other
Figure 7. Global AI Pharma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. AI Pharma Consumption Value Market Share by Application in 2024
Figure 9. Preclinical Stage (Optimization of Lead Compounds, etc.) Picture
Figure 10. ClinicalTrial Phase (PredictingTreatment Outcome, etc.) Picture
Figure 11. Global AI Pharma Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global AI Pharma Consumption Value andForecast (2020-2031) & (USD Million)
Figure 13. Global Market AI Pharma Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global AI Pharma Consumption Value Market Share by Region (2020-2031)
Figure 15. Global AI Pharma Consumption Value Market Share by Region in 2024
Figure 16. North America AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 19. South America AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 21. CompanyThree Recent Developments andFuture Plans
Figure 22. Global AI Pharma Revenue Share by Players in 2024
Figure 23. AI Pharma Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 24. Market Share of AI Pharma by Player Revenue in 2024
Figure 25.Top 3 AI Pharma Players Market Share in 2024
Figure 26.Top 6 AI Pharma Players Market Share in 2024
Figure 27. Global AI Pharma Consumption Value Share byType (2020-2025)
Figure 28. Global AI Pharma Market ShareForecast byType (2026-2031)
Figure 29. Global AI Pharma Consumption Value Share by Application (2020-2025)
Figure 30. Global AI Pharma Market ShareForecast by Application (2026-2031)
Figure 31. North America AI Pharma Consumption Value Market Share byType (2020-2031)
Figure 32. North America AI Pharma Consumption Value Market Share by Application (2020-2031)
Figure 33. North America AI Pharma Consumption Value Market Share by Country (2020-2031)
Figure 34. United States AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe AI Pharma Consumption Value Market Share byType (2020-2031)
Figure 38. Europe AI Pharma Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe AI Pharma Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 41.France AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific AI Pharma Consumption Value Market Share byType (2020-2031)
Figure 46. Asia-Pacific AI Pharma Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific AI Pharma Consumption Value Market Share by Region (2020-2031)
Figure 48. China AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 51. India AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 54. South America AI Pharma Consumption Value Market Share byType (2020-2031)
Figure 55. South America AI Pharma Consumption Value Market Share by Application (2020-2031)
Figure 56. South America AI Pharma Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa AI Pharma Consumption Value Market Share byType (2020-2031)
Figure 60. Middle East & Africa AI Pharma Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa AI Pharma Consumption Value Market Share by Country (2020-2031)
Figure 62.Turkey AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 65. AI Pharma Market Drivers
Figure 66. AI Pharma Market Restraints
Figure 67. AI Pharma MarketTrends
Figure 68. PortersFiveForces Analysis
Figure 69. AI Pharma Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Pharma by Type
1.3.1 Overview: Global AI Pharma Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global AI Pharma Consumption Value Market Share by Type in 2024
1.3.3 Self-developed Oipeline
1.3.4 Contract Research Organization (CRO)
1.3.5 Other
1.4 Global AI Pharma Market by Application
1.4.1 Overview: Global AI Pharma Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Preclinical Stage (Optimization of Lead Compounds, etc.)
1.4.3 Clinical Trial Phase (Predicting Treatment Outcome, etc.)
1.5 Global AI Pharma Market Size & Forecast
1.6 Global AI Pharma Market Size and Forecast by Region
1.6.1 Global AI Pharma Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global AI Pharma Market Size by Region, (2020-2031)
1.6.3 North America AI Pharma Market Size and Prospect (2020-2031)
1.6.4 Europe AI Pharma Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific AI Pharma Market Size and Prospect (2020-2031)
1.6.6 South America AI Pharma Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa AI Pharma Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Recursion
2.1.1 Recursion Details
2.1.2 Recursion Major Business
2.1.3 Recursion AI Pharma Product and Solutions
2.1.4 Recursion AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Recursion Recent Developments and Future Plans
2.2 Insilico Medicine
2.2.1 Insilico Medicine Details
2.2.2 Insilico Medicine Major Business
2.2.3 Insilico Medicine AI Pharma Product and Solutions
2.2.4 Insilico Medicine AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Insilico Medicine Recent Developments and Future Plans
2.3 Exscientia
2.3.1 Exscientia Details
2.3.2 Exscientia Major Business
2.3.3 Exscientia AI Pharma Product and Solutions
2.3.4 Exscientia AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Exscientia Recent Developments and Future Plans
2.4 BenevolentAI
2.4.1 BenevolentAI Details
2.4.2 BenevolentAI Major Business
2.4.3 BenevolentAI AI Pharma Product and Solutions
2.4.4 BenevolentAI AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 BenevolentAI Recent Developments and Future Plans
2.5 Atomwise
2.5.1 Atomwise Details
2.5.2 Atomwise Major Business
2.5.3 Atomwise AI Pharma Product and Solutions
2.5.4 Atomwise AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Atomwise Recent Developments and Future Plans
2.6 Roivant Sciences
2.6.1 Roivant Sciences Details
2.6.2 Roivant Sciences Major Business
2.6.3 Roivant Sciences AI Pharma Product and Solutions
2.6.4 Roivant Sciences AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Roivant Sciences Recent Developments and Future Plans
2.7 Schrцdinger
2.7.1 Schrцdinger Details
2.7.2 Schrцdinger Major Business
2.7.3 Schrцdinger AI Pharma Product and Solutions
2.7.4 Schrцdinger AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Schrцdinger Recent Developments and Future Plans
2.8 Lantern Pharma
2.8.1 Lantern Pharma Details
2.8.2 Lantern Pharma Major Business
2.8.3 Lantern Pharma AI Pharma Product and Solutions
2.8.4 Lantern Pharma AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Lantern Pharma Recent Developments and Future Plans
2.9 XtalPi
2.9.1 XtalPi Details
2.9.2 XtalPi Major Business
2.9.3 XtalPi AI Pharma Product and Solutions
2.9.4 XtalPi AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 XtalPi Recent Developments and Future Plans
2.10 Landos Biopharma
2.10.1 Landos Biopharma Details
2.10.2 Landos Biopharma Major Business
2.10.3 Landos Biopharma AI Pharma Product and Solutions
2.10.4 Landos Biopharma AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Landos Biopharma Recent Developments and Future Plans
2.11 Relay Therapeutics
2.11.1 Relay Therapeutics Details
2.11.2 Relay Therapeutics Major Business
2.11.3 Relay Therapeutics AI Pharma Product and Solutions
2.11.4 Relay Therapeutics AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Relay Therapeutics Recent Developments and Future Plans
2.12 Accutar Biotech
2.12.1 Accutar Biotech Details
2.12.2 Accutar Biotech Major Business
2.12.3 Accutar Biotech AI Pharma Product and Solutions
2.12.4 Accutar Biotech AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Accutar Biotech Recent Developments and Future Plans
2.13 Deep Genomics
2.13.1 Deep Genomics Details
2.13.2 Deep Genomics Major Business
2.13.3 Deep Genomics AI Pharma Product and Solutions
2.13.4 Deep Genomics AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Deep Genomics Recent Developments and Future Plans
2.14 Oncocross
2.14.1 Oncocross Details
2.14.2 Oncocross Major Business
2.14.3 Oncocross AI Pharma Product and Solutions
2.14.4 Oncocross AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Oncocross Recent Developments and Future Plans
2.15 AI Therapeutics
2.15.1 AI Therapeutics Details
2.15.2 AI Therapeutics Major Business
2.15.3 AI Therapeutics AI Pharma Product and Solutions
2.15.4 AI Therapeutics AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 AI Therapeutics Recent Developments and Future Plans
2.16 BioMap
2.16.1 BioMap Details
2.16.2 BioMap Major Business
2.16.3 BioMap AI Pharma Product and Solutions
2.16.4 BioMap AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 BioMap Recent Developments and Future Plans
2.17 METiS Pharmaceuticals
2.17.1 METiS Pharmaceuticals Details
2.17.2 METiS Pharmaceuticals Major Business
2.17.3 METiS Pharmaceuticals AI Pharma Product and Solutions
2.17.4 METiS Pharmaceuticals AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 METiS Pharmaceuticals Recent Developments and Future Plans
2.18 NeoX Biotech
2.18.1 NeoX Biotech Details
2.18.2 NeoX Biotech Major Business
2.18.3 NeoX Biotech AI Pharma Product and Solutions
2.18.4 NeoX Biotech AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 NeoX Biotech Recent Developments and Future Plans
2.19 StoneWise
2.19.1 StoneWise Details
2.19.2 StoneWise Major Business
2.19.3 StoneWise AI Pharma Product and Solutions
2.19.4 StoneWise AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 StoneWise Recent Developments and Future Plans
2.20 Deep Intelligent Pharma
2.20.1 Deep Intelligent Pharma Details
2.20.2 Deep Intelligent Pharma Major Business
2.20.3 Deep Intelligent Pharma AI Pharma Product and Solutions
2.20.4 Deep Intelligent Pharma AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Deep Intelligent Pharma Recent Developments and Future Plans
2.21 Gigaceuticals
2.21.1 Gigaceuticals Details
2.21.2 Gigaceuticals Major Business
2.21.3 Gigaceuticals AI Pharma Product and Solutions
2.21.4 Gigaceuticals AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Gigaceuticals Recent Developments and Future Plans
2.22 Chemical.AI
2.22.1 Chemical.AI Details
2.22.2 Chemical.AI Major Business
2.22.3 Chemical.AI AI Pharma Product and Solutions
2.22.4 Chemical.AI AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Chemical.AI Recent Developments and Future Plans
2.23 Artivila
2.23.1 Artivila Details
2.23.2 Artivila Major Business
2.23.3 Artivila AI Pharma Product and Solutions
2.23.4 Artivila AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Artivila Recent Developments and Future Plans
2.24 Galixir
2.24.1 Galixir Details
2.24.2 Galixir Major Business
2.24.3 Galixir AI Pharma Product and Solutions
2.24.4 Galixir AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 Galixir Recent Developments and Future Plans
2.25 Xbiome
2.25.1 Xbiome Details
2.25.2 Xbiome Major Business
2.25.3 Xbiome AI Pharma Product and Solutions
2.25.4 Xbiome AI Pharma Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Xbiome Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Pharma Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of AI Pharma by Company Revenue
3.2.2 Top 3 AI Pharma Players Market Share in 2024
3.2.3 Top 6 AI Pharma Players Market Share in 2024
3.3 AI Pharma Market: Overall Company Footprint Analysis
3.3.1 AI Pharma Market: Region Footprint
3.3.2 AI Pharma Market: Company Product Type Footprint
3.3.3 AI Pharma Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Pharma Consumption Value and Market Share by Type (2020-2025)
4.2 Global AI Pharma Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Pharma Consumption Value Market Share by Application (2020-2025)
5.2 Global AI Pharma Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America AI Pharma Consumption Value by Type (2020-2031)
6.2 North America AI Pharma Market Size by Application (2020-2031)
6.3 North America AI Pharma Market Size by Country
6.3.1 North America AI Pharma Consumption Value by Country (2020-2031)
6.3.2 United States AI Pharma Market Size and Forecast (2020-2031)
6.3.3 Canada AI Pharma Market Size and Forecast (2020-2031)
6.3.4 Mexico AI Pharma Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe AI Pharma Consumption Value by Type (2020-2031)
7.2 Europe AI Pharma Consumption Value by Application (2020-2031)
7.3 Europe AI Pharma Market Size by Country
7.3.1 Europe AI Pharma Consumption Value by Country (2020-2031)
7.3.2 Germany AI Pharma Market Size and Forecast (2020-2031)
7.3.3 France AI Pharma Market Size and Forecast (2020-2031)
7.3.4 United Kingdom AI Pharma Market Size and Forecast (2020-2031)
7.3.5 Russia AI Pharma Market Size and Forecast (2020-2031)
7.3.6 Italy AI Pharma Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Pharma Consumption Value by Type (2020-2031)
8.2 Asia-Pacific AI Pharma Consumption Value by Application (2020-2031)
8.3 Asia-Pacific AI Pharma Market Size by Region
8.3.1 Asia-Pacific AI Pharma Consumption Value by Region (2020-2031)
8.3.2 China AI Pharma Market Size and Forecast (2020-2031)
8.3.3 Japan AI Pharma Market Size and Forecast (2020-2031)
8.3.4 South Korea AI Pharma Market Size and Forecast (2020-2031)
8.3.5 India AI Pharma Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia AI Pharma Market Size and Forecast (2020-2031)
8.3.7 Australia AI Pharma Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America AI Pharma Consumption Value by Type (2020-2031)
9.2 South America AI Pharma Consumption Value by Application (2020-2031)
9.3 South America AI Pharma Market Size by Country
9.3.1 South America AI Pharma Consumption Value by Country (2020-2031)
9.3.2 Brazil AI Pharma Market Size and Forecast (2020-2031)
9.3.3 Argentina AI Pharma Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Pharma Consumption Value by Type (2020-2031)
10.2 Middle East & Africa AI Pharma Consumption Value by Application (2020-2031)
10.3 Middle East & Africa AI Pharma Market Size by Country
10.3.1 Middle East & Africa AI Pharma Consumption Value by Country (2020-2031)
10.3.2 Turkey AI Pharma Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia AI Pharma Market Size and Forecast (2020-2031)
10.3.4 UAE AI Pharma Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 AI Pharma Market Drivers
11.2 AI Pharma Market Restraints
11.3 AI Pharma Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Pharma Industry Chain
12.2 AI Pharma Upstream Analysis
12.3 AI Pharma Midstream Analysis
12.4 AI Pharma Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global AI Pharma Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global AI Pharma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global AI Pharma Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global AI Pharma Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Recursion Company Information, Head Office, and Major Competitors
Table 6. Recursion Major Business
Table 7. Recursion AI Pharma Product and Solutions
Table 8. Recursion AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Recursion Recent Developments andFuture Plans
Table 10. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 11. Insilico Medicine Major Business
Table 12. Insilico Medicine AI Pharma Product and Solutions
Table 13. Insilico Medicine AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Insilico Medicine Recent Developments andFuture Plans
Table 15. Exscientia Company Information, Head Office, and Major Competitors
Table 16. Exscientia Major Business
Table 17. Exscientia AI Pharma Product and Solutions
Table 18. Exscientia AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. BenevolentAI Company Information, Head Office, and Major Competitors
Table 20. BenevolentAI Major Business
Table 21. BenevolentAI AI Pharma Product and Solutions
Table 22. BenevolentAI AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. BenevolentAI Recent Developments andFuture Plans
Table 24. Atomwise Company Information, Head Office, and Major Competitors
Table 25. Atomwise Major Business
Table 26. Atomwise AI Pharma Product and Solutions
Table 27. Atomwise AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Atomwise Recent Developments andFuture Plans
Table 29. Roivant Sciences Company Information, Head Office, and Major Competitors
Table 30. Roivant Sciences Major Business
Table 31. Roivant Sciences AI Pharma Product and Solutions
Table 32. Roivant Sciences AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Roivant Sciences Recent Developments andFuture Plans
Table 34. Schrцdinger Company Information, Head Office, and Major Competitors
Table 35. Schrцdinger Major Business
Table 36. Schrцdinger AI Pharma Product and Solutions
Table 37. Schrцdinger AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Schrцdinger Recent Developments andFuture Plans
Table 39. Lantern Pharma Company Information, Head Office, and Major Competitors
Table 40. Lantern Pharma Major Business
Table 41. Lantern Pharma AI Pharma Product and Solutions
Table 42. Lantern Pharma AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Lantern Pharma Recent Developments andFuture Plans
Table 44. XtalPi Company Information, Head Office, and Major Competitors
Table 45. XtalPi Major Business
Table 46. XtalPi AI Pharma Product and Solutions
Table 47. XtalPi AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. XtalPi Recent Developments andFuture Plans
Table 49. Landos Biopharma Company Information, Head Office, and Major Competitors
Table 50. Landos Biopharma Major Business
Table 51. Landos Biopharma AI Pharma Product and Solutions
Table 52. Landos Biopharma AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Landos Biopharma Recent Developments andFuture Plans
Table 54. RelayTherapeutics Company Information, Head Office, and Major Competitors
Table 55. RelayTherapeutics Major Business
Table 56. RelayTherapeutics AI Pharma Product and Solutions
Table 57. RelayTherapeutics AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. RelayTherapeutics Recent Developments andFuture Plans
Table 59. Accutar Biotech Company Information, Head Office, and Major Competitors
Table 60. Accutar Biotech Major Business
Table 61. Accutar Biotech AI Pharma Product and Solutions
Table 62. Accutar Biotech AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Accutar Biotech Recent Developments andFuture Plans
Table 64. Deep Genomics Company Information, Head Office, and Major Competitors
Table 65. Deep Genomics Major Business
Table 66. Deep Genomics AI Pharma Product and Solutions
Table 67. Deep Genomics AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Deep Genomics Recent Developments andFuture Plans
Table 69. Oncocross Company Information, Head Office, and Major Competitors
Table 70. Oncocross Major Business
Table 71. Oncocross AI Pharma Product and Solutions
Table 72. Oncocross AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Oncocross Recent Developments andFuture Plans
Table 74. AITherapeutics Company Information, Head Office, and Major Competitors
Table 75. AITherapeutics Major Business
Table 76. AITherapeutics AI Pharma Product and Solutions
Table 77. AITherapeutics AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. AITherapeutics Recent Developments andFuture Plans
Table 79. BioMap Company Information, Head Office, and Major Competitors
Table 80. BioMap Major Business
Table 81. BioMap AI Pharma Product and Solutions
Table 82. BioMap AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. BioMap Recent Developments andFuture Plans
Table 84. METiS Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 85. METiS Pharmaceuticals Major Business
Table 86. METiS Pharmaceuticals AI Pharma Product and Solutions
Table 87. METiS Pharmaceuticals AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. METiS Pharmaceuticals Recent Developments andFuture Plans
Table 89. NeoX Biotech Company Information, Head Office, and Major Competitors
Table 90. NeoX Biotech Major Business
Table 91. NeoX Biotech AI Pharma Product and Solutions
Table 92. NeoX Biotech AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. NeoX Biotech Recent Developments andFuture Plans
Table 94. StoneWise Company Information, Head Office, and Major Competitors
Table 95. StoneWise Major Business
Table 96. StoneWise AI Pharma Product and Solutions
Table 97. StoneWise AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 98. StoneWise Recent Developments andFuture Plans
Table 99. Deep Intelligent Pharma Company Information, Head Office, and Major Competitors
Table 100. Deep Intelligent Pharma Major Business
Table 101. Deep Intelligent Pharma AI Pharma Product and Solutions
Table 102. Deep Intelligent Pharma AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 103. Deep Intelligent Pharma Recent Developments andFuture Plans
Table 104. Gigaceuticals Company Information, Head Office, and Major Competitors
Table 105. Gigaceuticals Major Business
Table 106. Gigaceuticals AI Pharma Product and Solutions
Table 107. Gigaceuticals AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 108. Gigaceuticals Recent Developments andFuture Plans
Table 109. Chemical.AI Company Information, Head Office, and Major Competitors
Table 110. Chemical.AI Major Business
Table 111. Chemical.AI AI Pharma Product and Solutions
Table 112. Chemical.AI AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 113. Chemical.AI Recent Developments andFuture Plans
Table 114. Artivila Company Information, Head Office, and Major Competitors
Table 115. Artivila Major Business
Table 116. Artivila AI Pharma Product and Solutions
Table 117. Artivila AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 118. Artivila Recent Developments andFuture Plans
Table 119. Galixir Company Information, Head Office, and Major Competitors
Table 120. Galixir Major Business
Table 121. Galixir AI Pharma Product and Solutions
Table 122. Galixir AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 123. Galixir Recent Developments andFuture Plans
Table 124. Xbiome Company Information, Head Office, and Major Competitors
Table 125. Xbiome Major Business
Table 126. Xbiome AI Pharma Product and Solutions
Table 127. Xbiome AI Pharma Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 128. Xbiome Recent Developments andFuture Plans
Table 129. Global AI Pharma Revenue (USD Million) by Players (2020-2025)
Table 130. Global AI Pharma Revenue Share by Players (2020-2025)
Table 131. Breakdown of AI Pharma by CompanyType (Tier 1,Tier 2, andTier 3)
Table 132. Market Position of Players in AI Pharma, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 133. Head Office of Key AI Pharma Players
Table 134. AI Pharma Market: Company ProductTypeFootprint
Table 135. AI Pharma Market: Company Product ApplicationFootprint
Table 136. AI Pharma New Market Entrants and Barriers to Market Entry
Table 137. AI Pharma Mergers, Acquisition, Agreements, and Collaborations
Table 138. Global AI Pharma Consumption Value (USD Million) byType (2020-2025)
Table 139. Global AI Pharma Consumption Value Share byType (2020-2025)
Table 140. Global AI Pharma Consumption ValueForecast byType (2026-2031)
Table 141. Global AI Pharma Consumption Value by Application (2020-2025)
Table 142. Global AI Pharma Consumption ValueForecast by Application (2026-2031)
Table 143. North America AI Pharma Consumption Value byType (2020-2025) & (USD Million)
Table 144. North America AI Pharma Consumption Value byType (2026-2031) & (USD Million)
Table 145. North America AI Pharma Consumption Value by Application (2020-2025) & (USD Million)
Table 146. North America AI Pharma Consumption Value by Application (2026-2031) & (USD Million)
Table 147. North America AI Pharma Consumption Value by Country (2020-2025) & (USD Million)
Table 148. North America AI Pharma Consumption Value by Country (2026-2031) & (USD Million)
Table 149. Europe AI Pharma Consumption Value byType (2020-2025) & (USD Million)
Table 150. Europe AI Pharma Consumption Value byType (2026-2031) & (USD Million)
Table 151. Europe AI Pharma Consumption Value by Application (2020-2025) & (USD Million)
Table 152. Europe AI Pharma Consumption Value by Application (2026-2031) & (USD Million)
Table 153. Europe AI Pharma Consumption Value by Country (2020-2025) & (USD Million)
Table 154. Europe AI Pharma Consumption Value by Country (2026-2031) & (USD Million)
Table 155. Asia-Pacific AI Pharma Consumption Value byType (2020-2025) & (USD Million)
Table 156. Asia-Pacific AI Pharma Consumption Value byType (2026-2031) & (USD Million)
Table 157. Asia-Pacific AI Pharma Consumption Value by Application (2020-2025) & (USD Million)
Table 158. Asia-Pacific AI Pharma Consumption Value by Application (2026-2031) & (USD Million)
Table 159. Asia-Pacific AI Pharma Consumption Value by Region (2020-2025) & (USD Million)
Table 160. Asia-Pacific AI Pharma Consumption Value by Region (2026-2031) & (USD Million)
Table 161. South America AI Pharma Consumption Value byType (2020-2025) & (USD Million)
Table 162. South America AI Pharma Consumption Value byType (2026-2031) & (USD Million)
Table 163. South America AI Pharma Consumption Value by Application (2020-2025) & (USD Million)
Table 164. South America AI Pharma Consumption Value by Application (2026-2031) & (USD Million)
Table 165. South America AI Pharma Consumption Value by Country (2020-2025) & (USD Million)
Table 166. South America AI Pharma Consumption Value by Country (2026-2031) & (USD Million)
Table 167. Middle East & Africa AI Pharma Consumption Value byType (2020-2025) & (USD Million)
Table 168. Middle East & Africa AI Pharma Consumption Value byType (2026-2031) & (USD Million)
Table 169. Middle East & Africa AI Pharma Consumption Value by Application (2020-2025) & (USD Million)
Table 170. Middle East & Africa AI Pharma Consumption Value by Application (2026-2031) & (USD Million)
Table 171. Middle East & Africa AI Pharma Consumption Value by Country (2020-2025) & (USD Million)
Table 172. Middle East & Africa AI Pharma Consumption Value by Country (2026-2031) & (USD Million)
Table 173. Global Key Players of AI Pharma Upstream (Raw Materials)
Table 174. Global AI PharmaTypical Customers
LIST OFFIGURES
Figure 1. AI Pharma Picture
Figure 2. Global AI Pharma Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global AI Pharma Consumption Value Market Share byType in 2024
Figure 4. Self-developed Oipeline
Figure 5. Contract Research Organization (CRO)
Figure 6. Other
Figure 7. Global AI Pharma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. AI Pharma Consumption Value Market Share by Application in 2024
Figure 9. Preclinical Stage (Optimization of Lead Compounds, etc.) Picture
Figure 10. ClinicalTrial Phase (PredictingTreatment Outcome, etc.) Picture
Figure 11. Global AI Pharma Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global AI Pharma Consumption Value andForecast (2020-2031) & (USD Million)
Figure 13. Global Market AI Pharma Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global AI Pharma Consumption Value Market Share by Region (2020-2031)
Figure 15. Global AI Pharma Consumption Value Market Share by Region in 2024
Figure 16. North America AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 19. South America AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 21. CompanyThree Recent Developments andFuture Plans
Figure 22. Global AI Pharma Revenue Share by Players in 2024
Figure 23. AI Pharma Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 24. Market Share of AI Pharma by Player Revenue in 2024
Figure 25.Top 3 AI Pharma Players Market Share in 2024
Figure 26.Top 6 AI Pharma Players Market Share in 2024
Figure 27. Global AI Pharma Consumption Value Share byType (2020-2025)
Figure 28. Global AI Pharma Market ShareForecast byType (2026-2031)
Figure 29. Global AI Pharma Consumption Value Share by Application (2020-2025)
Figure 30. Global AI Pharma Market ShareForecast by Application (2026-2031)
Figure 31. North America AI Pharma Consumption Value Market Share byType (2020-2031)
Figure 32. North America AI Pharma Consumption Value Market Share by Application (2020-2031)
Figure 33. North America AI Pharma Consumption Value Market Share by Country (2020-2031)
Figure 34. United States AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe AI Pharma Consumption Value Market Share byType (2020-2031)
Figure 38. Europe AI Pharma Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe AI Pharma Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 41.France AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific AI Pharma Consumption Value Market Share byType (2020-2031)
Figure 46. Asia-Pacific AI Pharma Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific AI Pharma Consumption Value Market Share by Region (2020-2031)
Figure 48. China AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 51. India AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 54. South America AI Pharma Consumption Value Market Share byType (2020-2031)
Figure 55. South America AI Pharma Consumption Value Market Share by Application (2020-2031)
Figure 56. South America AI Pharma Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa AI Pharma Consumption Value Market Share byType (2020-2031)
Figure 60. Middle East & Africa AI Pharma Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa AI Pharma Consumption Value Market Share by Country (2020-2031)
Figure 62.Turkey AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE AI Pharma Consumption Value (2020-2031) & (USD Million)
Figure 65. AI Pharma Market Drivers
Figure 66. AI Pharma Market Restraints
Figure 67. AI Pharma MarketTrends
Figure 68. PortersFiveForces Analysis
Figure 69. AI Pharma Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
More Publications
Global Traffic Variable Message Signs (VMS) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
May 2022
117 pages
Global Occupant Classification System (OCS) Sensor Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
October 2024
114 pages
Global Consumer Internet of Things (CIoT) Market 2024 by Company, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
August 2024
123 pages
Global SAP Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
January 2026
145 pages
Global Intelligent Building Management Systems Market 2022 by Company, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
March 2022
85 pages
